Join the club for FREE to access the whole archive and other member benefits.

Jeffrey Rosenfeld

Director of Monash Institute of Medical Engineering and Senior Neurosurgeon at Alfred Hospital.

Professor Rosenfeld is one of Australia’s leading academic neurosurgeons and is internationally recognised. He was co-Principal Investigator on the landmark Decompressive Craniectomy Study, the first multicentre randomised controlled trial of this procedure which was published in the New England Journal of Medicine (NEJM) in 2011. He has been an invited Visiting Professor in 12 countries and an invited speaker for 12 named orations and 65 international meetings. He has published over 280 peer reviewed articles (including Lancet, Lancet Neurology and NEJM), 46 book chapters and 2 books. Professor Rosenfeld has had 10,943 citations, h-index of 52 and i10-index of 164 based on Google Scholar data 2 January 2018 and has over his career been awarded $22 million of competitive grant funding including $9.9 million from the ARC and $6.62 million from the NH&MRC. He has been appointed to the Editorial Board of 10 international journals and is a reviewer for 36 international journals. He is a Principal Investigator within the Monash Bionic Vision Group which aims to develop a bionic vision direct to brain implant with a first-in-human implant in 2018 and was awarded $8 million by the Australian Research Council in 2009.

Visit website:

 Login to view link, or join the club to get full access to all resources and other benefits.

 Login to view link, or join the club to get full access to all resources and other benefits.

See also: Academia Monash University - Public Research university.

Jeffrey Rosenfeld News

Gennaris bionic eye receives ethics approval

SBS News - 06-Jun-2018

Vision Group recently was able to create enough devices to start human trials